Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Malboro Maker Invests $2.4 Billion into Cannabis Company

Stockhouse Editorial
0 Comments| December 7, 2018

{{labelSign}}  Favorites
{{errorMessage}}

One of the largest tobacco companies in the world is getting into the cannabis game.

Altria , owner of Marlboro cigarettes, is making a $2.4 billion (USD) investmentinto Canadian medical and recreational marijuana company Cronos Group.

The investment is a 45% stake and Altria could pay another $1.4 billion for warrants that would increase its stake to 55% over the next five years.

Over this past year, Altria’s stock (NYSE:MO) has fallen nearly 5%, but its shares rose 25% Friday after this news was released and Cronos (NASDQ:CRON) rose 30%.


This news comes on the heels of a major investment made by multinational beverage giant Constellation Brands Inc. (NYSE: STZ) (maker of Corona Beer) to the tune of $245 million (CAD)in cannabis industry leader, Canopy Growth Corp. (TSX: WEED).

Nearly three months ago, Aurora Cannabis (TSX:ACB) made headlines when reports were rampant that it had been working on a deal with Coca-Cola. While the news was a boost to its stock, nothing further had been mentioned publicly.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today